Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: Dilly who wrote (1867)	7/29/1999 12:58:00 AM
From: Marshall Teitelbaum	Read Replies (1) \| Respond to of 2205

Dilly and all, Worth taking a look at the patent of the 27th: 164.195.100.11 Looks extremely important and maybe even to be playing a role in the recent move. Goes over how to induce proper cartilage development, including how to induce from differing cell types and how to cause production of the proper makeup of good articular cartilage. Speaks of having a solid method to product artificial cartilage, and makes you wonder if the cartilage variable questions has been answered sufficiently enough now to merit going ahead with the human trial in the not too distant future(meaning avoiding a need for retrospective analysis as occurred with DG).......just thoughts, and only confirmation is truly confirmation. Regards, Marshall